All In Biotech

Drug Trial Radar · NCT00683137

Analgesic Efficacy And Safety of Valdecoxib For Treatment Of Post-Surgical Pain From Bunionectomy Surgery

Clinical Protocol for a Multiple Dose Randomized, Double-Blind, Placebo Controlled Study of the Analgesic Efficacy and Safety of Valdecoxib Compared to Placebo in Patients for Treatment of Post-Surgical Pain From Bunionectomy Surgery

Last checked: Nov 20, 2026Latest source record: May 23, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

450

Actual

Start

Oct 2002

Primary completion

Not stated

Study completion Feb 2003

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
May 23, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study was done to evaluate the pain relief and safety of 2 valdecoxib doses compared to placebo in patients with moderate or severe pain following bunionectomy surgery, and to evaluate the effect of the 2 valdecoxib doses compared to placebo on health outcome measures and on the occurrence of opioid related symptoms.

Conditions

  • Pain
  • Hallux Valgus

Interventions

  • valdecoxibDrug

    valdecoxib 40 mg tablet by mouth followed by a valdecoxib 20 mg tablet by mouth after 1 to 12 hours of the initial dose on Day 1 then a valdecoxib 20 mg tablet by mouth once daily on Days 2 through 5

  • valdecoxibDrug

    valdecoxib 40 mg tablet by mouth followed by a valdecoxib 20 mg tablet by mouth after 1 to 12 hours of the initial dose on Day 1 then a valdecoxib 20 mg tablet by mouth twice daily on Days 2 through 5

  • valdecoxib/placeboDrug

    valdecoxib 40 mg tablet by mouth followed by a valdecoxib 20 mg tablet by mouth after 1 to 12 hours of the initial dose on Day 1 then placebo on Days 2 through 5

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patient's Global Evaluation of Study MedicationTime frame: Day 2 and Day 3
  2. Summed Pain Intensity (SPI) (categorical) through 24 hoursTime frame: Day 2 and Day 3

Locations

89 sites in 1 country. Site status is shown where the registry gives one.

  • Pfizer Investigational Site

    Chandler, Arizona

  • Pfizer Investigational Site

    Glendale, Arizona

  • Pfizer Investigational Site

    Glendale, Arizona

  • Pfizer Investigational Site

    Mesa, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    Phoenix, Arizona

  • Pfizer Investigational Site

    National City, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    San Diego, California

  • Pfizer Investigational Site

    Milford, Connecticut

  • Pfizer Investigational Site

    New Haven, Connecticut

  • Pfizer Investigational Site

    New Haven, Connecticut

  • Pfizer Investigational Site

    Cooper City, Florida

  • Pfizer Investigational Site

    Cutler Ridge, Florida

  • Pfizer Investigational Site

    Fort Lauderdale, Florida

  • Pfizer Investigational Site

    Fort Lauderdale, Florida

  • Pfizer Investigational Site

    Hallandale, Florida

  • Pfizer Investigational Site

    Hollywood, Florida

  • Pfizer Investigational Site

    Hollywood, Florida

  • Pfizer Investigational Site

    Miami, Florida

  • Pfizer Investigational Site

    New Port Richey, Florida

  • Pfizer Investigational Site

    New Port Richey, Florida

  • Pfizer Investigational Site

    New Port Richey, Florida

  • Pfizer Investigational Site

    Pembroke Pines, Florida

  • Pfizer Investigational Site

    Pembroke Pines, Florida

  • Pfizer Investigational Site

    Port Richey, Florida

  • Pfizer Investigational Site

    South Miami, Florida

  • Pfizer Investigational Site

    Spring Hill, Florida

  • Pfizer Investigational Site

    Addison, Illinois

  • Pfizer Investigational Site

    Elk Grove Village, Illinois

  • Pfizer Investigational Site

    Peoria, Illinois

  • Pfizer Investigational Site

    Peoria, Illinois

  • Pfizer Investigational Site

    Peoria, Illinois

  • Pfizer Investigational Site

    Evansville, Indiana

Showing 40 of 89 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.